Keros Therapeutics Inc
KROS
Insider trades and stock quote 2022-2024
11/4/2023
| Sell | Regnante, Keith |
Chief Financial Officer
|
$45.3
|
$1,811,600
|
6/9/2023
| Sell | Regnante, Keith |
Chief Financial Officer
|
$46.3
|
$908,368
|
6/8/2023
| Sell | Regnante, Keith |
Chief Financial Officer
|
$48.2
|
$955,872
|
7/15/2022
| Sell | Lachey, Jennifer |
Chief Scientific Officer
|
$30.0
|
$1,381,020
|
7/13/2022
| Sell | Lachey, Jennifer |
Chief Scientific Officer
|
$30.0
|
$57,480
|
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)